Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Latest filing published 05 Nov 2019 for ResMed Inc.
Filing timeline
BuySaleJohn P. Wareham
Insider track record
Disclosed buys
0
Disclosed sells
27
Signal history
John P. Wareham: trading record in brief
Filings by John P. Wareham span 5 companies, the busiest being ResMed Inc, Steris Corp and Integer Holdings Corp. In total, 90 filings cover trades dated from 30 December 2005 to 4 November 2019.
Sales make up the whole of the open-market record (27 sales, €22.2M). Outside the open market, there are 24 share grants and 34 option exercises. So far in 2019, the count stands at no purchases and 6 sales.
On 5 November 2019 came the latest disclosure, a transaction in ResMed Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John P. Wareham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations87 total
1,100 shares0ResMed Common StockSEC:0001127602-19-031852:6
5,956 shares@ US$148.007.6% of flowResMed Common StockSEC:0001127602-19-031852:5
9,536 shares@ US$58.244.8% of flowResMed Common StockSEC:0001127602-19-031852:0
9,536 shares@ US$148.1512.2% of flowResMed Common StockSEC:0001127602-19-031852:1
5,000 shares@ US$58.242.5% of flowResMed Common StockSEC:0001127602-19-031852:2
5,000 shares@ US$147.756.4% of flowResMed Common StockSEC:0001127602-19-031852:3
5,956 shares@ US$58.243.0% of flowResMed Common StockSEC:0001127602-19-031852:4
600 shares0ResMed Common StockSEC:0001127602-19-025751:0
11,085 shares@ US$51.254.9% of flowResMed Common StockSEC:0001127602-19-020022:0
11,085 shares@ US$113.4410.9% of flowResMed Common StockSEC:0001127602-19-020022:1
9,628 shares@ US$51.254.3% of flowResMed Common StockSEC:0001127602-19-020022:2
9,628 shares@ US$114.009.5% of flowResMed Common StockSEC:0001127602-19-020022:3
23,629 shares@ US$52.0210.6% of flowResMed Common StockSEC:0001127602-19-020022:4
23,629 shares@ US$114.0023.3% of flowResMed Common StockSEC:0001127602-19-020022:5
25,934 shares@ US$38.984.5% of flowResMed Common StockSEC:0001140361-18-003498:0
17,634 shares@ US$102.098.0% of flowResMed Common StockSEC:0001140361-18-003498:1
8,300 shares@ US$102.603.8% of flowResMed Common StockSEC:0001140361-18-003498:2
28,403 shares@ US$71.7710.5% of flowResMed Common StockSEC:0001140361-17-009665:1
28,403 shares@ US$27.584.1% of flowResMed Common StockSEC:0001140361-17-009665:0
24,390 shares@ US$33.704.1% of flowResMed Common StockSEC:0001140361-16-075598:0
24,390 shares@ US$70.328.5% of flowResMed Common StockSEC:0001140361-16-075598:1
31,560 sharesOrdinary Shares, ?0.10 Nominal ValueSEC:0001209191-15-077846:0
31,560 sharesCommon Shares, No Par ValueSEC:0001209191-15-077685:0
4,390 shares@ US$34.17Common Shares, No Par ValueSEC:0001181431-15-002325:0
2,270 shares@ US$66.10Common Shares, No Par ValueSEC:0001181431-15-002325:1
25 of 87 declarations
